GENUS COMPLETES PRIVATE PLACEMENT
SUNNYVALE, CALIF. - NOVEMBER 7, 2003 - Genus, Inc. (Nasdaq: GGNS) today
announced that it has completed a private placement of approximately 6.4 million
shares of its common stock at a per share price of $5.25. The offering resulted
in gross proceeds to the company of approximately $33.0 million. The purchase
price of the shares represents approximately a 5 percent discount on the average
closing price for 10 days prior to the close on November 7, 2003. No warrants
were issued in this transaction.
The company stated that it expects to use the net proceeds of the offering for
working capital and general corporate purposes. Halpern Capital, Inc. acted as
the lead placement agent to Genus for this private placement.
This press release does not constitute an offer to sell or the solicitation of
an offer to buy any security. The shares have not been registered under the
Securities Act of 1933 or applicable state securities laws and may not be
offered or sold in the United States absent registration under the Securities
Act and applicable state securities laws or an applicable exemption from
registration requirements. Genus has agreed to file a registration statement
covering the resale of the shares.
Except for the historical information contained herein, the matters set forth in
this press release, including the expected use of proceeds of the offering, are
forward-looking statements within the meaning of the "safe harbor" provisions of
the Private Securities Litigation Reform Act of 1995. These forward-looking
statements are subject to risks and uncertainties that may cause actual results
to differ materially, including the effect of the offering on Genus' share
price, changing customer requirements, and the effects of technological advances
and competition. For a discussion of additional factors that may cause results
to differ, see Genus' SEC reports, including its Quarterly Report on Form 10-Q
for the quarter ended June 30, 2003 and Form 10-K for the year ended December
31, 2002. These forward-looking statements speak only as of the date hereof.
Genus disclaims any intent or obligation to update these forward-looking
statements.
ABOUT HALPERN CAPITAL:
Halpern Capital, Inc. is an "idea driven" sell-side equity research and
investment-banking boutique involved in facilitating management restructurings,
private placements and leveraged buyouts. Halpern Capital founded by Baruch
Halpern, has its offices in Florida and associates in New York, California and
Texas. The firm brings a flexible and focused approach to the private placement
in public entity (PIPE) market, offering a wide range of banking services on a
selective basis. Halpern Capital completed over $300 million in financings over
the last few years. Halpern Capital, Inc. is a NASD registered broker dealer.
Additional information can be found at www.halperncapital.com.
----------------------
ABOUT GENUS:
Genus, Inc. manufactures critical deposition processing products for the global
semiconductor industry and the data storage industry. To enable the production
of intricate micro computer chips and electronic storage devices, Genus offers
its STRATAGEM and LYNX series production-proven equipment for 200mm and 300mm
semiconductor production, and offers thin film deposition products for chemical
vapor deposition (CVD), atomic layer deposition (ALD), and pre-clean
capabilities. Genus is at the forefront of market and technology developments
in the ALD marketplace, which is gaining acceptance worldwide as a critical
technology for sub 0.13-micron production of computer chips and electronic
storage devices. Genus' customers include semiconductor and data storage
manufacturers located throughout the United States, Europe and the Pacific Rim
including Korea, Japan and Taiwan. Founded in 1981, the company is headquartered
in Sunnyvale, California. For additional information visit Genus' web site at
www.genus.com. STRATAGEM, LYNX2(R) and LYNX3(tm) are trademarks of Genus, Inc.
- -------------
# # #
-2-